Novartis AG

In News

Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation - novartis.com

novartis.com - Apr 01, 2026

Novartis Likely to Confirm Guidance -- Market Talk - Moomoo

Moomoo - Apr 02, 2026

Moody Lynn & Lieberson LLC Grows Stake in Novartis AG $NVS - MarketBeat

MarketBeat - Apr 01, 2026

Citi Reaffirms Their Buy Rating on Novartis AG (NOVN) - The Globe and Mail

The Globe and Mail - Mar 31, 2026

Novartis to Buy Breast Cancer Drug for as Much as $3 Billion - Bloomberg.com

Bloomberg.com - Mar 20, 2026

Novartis AG: The technical configuration is positive - MarketScreener

MarketScreener - Apr 01, 2026

Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance

Yahoo Finance - Mar 31, 2026

Novartis Whistleblower Advances Kickback Lawsuit Toward Trial - news.bloomberglaw.com

news.bloomberglaw.com - Mar 31, 2026

Novartis AG Stock: Resilient Pharma Leader with Strong Fundamentals and Strategic Growth Ahead for I - ad-hoc-news.de

ad-hoc-news.de - Apr 02, 2026

Shrier Wealth Management LLC Invests $3.32 Million in Novartis AG $NVS - MarketBeat

MarketBeat - Apr 01, 2026

Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3% - novartis.com

novartis.com - Mar 29, 2026

Novartis AG Rises Tuesday - Moomoo

Moomoo - Mar 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment